<DOC>
	<DOCNO>NCT00044265</DOCNO>
	<brief_summary>Ramipril ACE inhibitor market US treatment hypertension since 1991 . It show effective reduce systolic diastolic blood pressure adult use daily . ACE inhibitor frequently use treat hypertension child , however ramipril extensively test child , information regard efficacy safety would therefore benefit child . This study design demonstrate efficacy safety ramipril treatment hypertension child age 6 16 year .</brief_summary>
	<brief_title>Treatment Pediatric Hypertension With Altace Trial</brief_title>
	<detailed_description>In adult , common side effect include persistent dry mouth , dizziness , fatigue , headache . Rare case angioedema report . When used pregnancy second third trimester , ACE inhibitor cause injury even death develop fetus . When pregnancy detect , ramipril discontinue soon possible . Ramipril contraindicate patient hypersensitive product history angioedema relate previous treatment ACE inhibitor .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<criteria>Inclusion criterion : Males female age 6 16 year . All female subject ≥ 8 year age must negative urine pregnancy test must use acceptable method contraception , include abstinence , barrier method ( diaphragm condom ) , DepoProvera , oral contraceptive , duration study . Weight ≥ 20 kg . Parents/guardians must able demonstrate ability use home blood pressure device monitor blood pressure . Sitting systolic blood pressure sit diastolic blood pressure ≥ 95th percentile age , gender height ; diabetes mellitus chronic renal insufficiency ( evidence GFR 4070 mL/min/1.73 m2 ) sit systolic blood pressure sit diastolic blood pressure ≥ 90th percentile age , gender , height . Exclusion criterion : Severe hypertension document ( 1 ) Sitting systolic blood pressure sit diastolic blood pressure 20 mmHg 95th percentile age , gender , height without antihypertensive therapy , ( 2 ) Sitting systolic blood pressure sit diastolic blood pressure 12 mmHg 95th percentile age , gender , height receive active therapy , ( 3 ) hypertensive encephalopathy within previous 5 month . Currently receive one antihypertensive medication include : ACE inhibitor , angiotensin receptor inhibitor , beta blocker , calcium channel blocker , diuretic . Receiving lithium , potassium supplement , monoamine oxidase inhibitor , major tranquilizer ( Note : Stimulant medication behavioral disorder , corticosteroid , nonsteroidal antiinflammatory agent chronic pain management permit trial provide subject 's dosage anticipate remain unchanged throughout duration study . ) A history cardiomyopathy , clinically significant structural heart disease atrioventricular conduction disturbance , sick sinus syndrome , atrial flutter , atrial fibrillation , clinically significant bradycardia accessory bypass tract , clinical symptom congestive heart failure .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>ACE inhibitor</keyword>
	<keyword>high blood pressure</keyword>
	<keyword>pediatric</keyword>
</DOC>